NovaBay Pharmaceuticals, Inc. engages in the development and sales of scientifically-created and clinically-proven eyecare and skincare. The company is headquartered in Emeryville, California and currently employs 14 full-time employees. The company went IPO on 2007-10-26. The firm manufactures and sells its proprietary form of hypochlorous acid for the wound care market through its NeutroPhase and PhaseOne branded products. NeutroPhase and PhaseOne are used for cleansing and irrigation as part of surgical procedures, as well as treating wounds, burns, ulcers and other injuries.
Follow-Up Questions
NovaBay Pharmaceuticals Inc 'in CEO'su kimdir?
Mr. Justin Hall 2015 'den beri şirketle birlikte olan NovaBay Pharmaceuticals Inc 'in Chief Executive Officer 'ıdır.
NBY hissesinin fiyat performansı nasıl?
NBY 'in mevcut fiyatı $1.87 'dir, son işlem günde 3.04% increased etti.
NovaBay Pharmaceuticals Inc için ana iş temaları veya sektörler nelerdir?
NovaBay Pharmaceuticals Inc Pharmaceuticals endüstrisine ait ve sektör Health Care 'dir
Wall Street analistlerine göre, 2 analist NovaBay Pharmaceuticals Inc için analist derecelendirmeleri gerçekleştirdi, bunlar 1 güçlü al, 3 al, 1 tut, 0 sat ve 1 güçlü sat içermektedir
